Fineotex Chemical Limited has informed the Exchange regarding Appointment of Mr Chetan Shah as Non- Executive Independent Director of the company w.e.f. August 12, 2025.
FCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fineotex Chemical's board met on August 12, 2025 and approved its Q1 FY26 (quarter ended June 30, 2025) financial results along with several other items. On a consolidated basis, revenue grew ~14.4% quarter-on-quarter to about Rs. 13,707 lakhs, profit after tax rose ~24.3% to about Rs. 2,503 lakhs, and operational EBITDA increased ~18.4% to about Rs. 2,520 lakhs. Return on Invested Capital for the quarter stood at ~30.7% and volumes grew ~14.7% QoQ. The company also began commercial production at its new Ambernath manufacturing facility (3 lakh sq. ft.). Additionally, Mr. Chetan Shah was appointed as a Non-Executive Independent Director for five years, HSPN & Associates was appointed as Secretarial Auditor for a first term of five years, the 22nd AGM was scheduled for September 19, 2025, and 58,797 stock options were granted under the FCL-ESOP 2020 plan.
Strong QoQ earnings growth, healthy ROIC, and successful commissioning of the new Ambernath plant signal solid operational momentum. The board additions and AGM scheduling are routine governance items and are unlikely to move the stock on their own, though the new plant capacity could support future growth.